What Acrivon Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 3 |
| Sells | 9 | 9 |
| Total trades | 10 | 54 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 30,000 | 4,565,689 |
| Disposed | 18,754 | 136,716 |
| Net activity | +11,246 | +4,428,973 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Levin Michaela | Chief Business Officer | Aug 31 | Grant / award · A | +30,000 | — | — | 30,000 |
| Blume-Jensen Peter | President and CEO | Aug 25 | Open-market sale · S | −14,036 | $2.21 | −$31K | 2,230,052 |
| Peterson Katharine | Chief Accounting Officer | Aug 18 | Open-market sale · S | −101 | $2.01 | −$203 | 18,033 |
| Miller Mary | Chief Legal Officer | Aug 18 | Open-market sale · S | −185 | $2.01 | −$372 | 82,009 |
| Devroe Eric | Chief Operating Officer | Aug 18 | Open-market sale · S | −604 | $2.01 | −$1.21K | 146,349 |
| Gamelin Erick | Chief Development Officer | Aug 18 | Open-market sale · S | −400 | $2.01 | −$804 | 52,592 |
| Blume-Jensen Peter | President and CEO | Aug 18 | Open-market sale · S | −484 | $2.01 | −$973 | 385,859 |
| Blume-Jensen Peter | President and CEO | Aug 18 | Open-market sale · S | −1,229 | $2.01 | −$2.47K | 2,244,088 |
| Levy Adam D. | Chief Financial Officer | Aug 04 | Open-market sale · S | −1,142 | $1.57 | −$1.79K | 66,008 |
| Miller Mary | Chief Legal Officer | Jul 21 | Open-market sale · S | −573 | $1.76 | −$1.01K | 82,194 |
| Blume-Jensen Peter | President and CEO | May 21 | Withheld — tax / exercise cost · F | −13,729 | $1.79 | −$24.6K | 2,245,317 |
| Blume-Jensen Peter | President and CEO | May 18 | Grant / award · A | +72,706 | — | — | 386,343 |
| Blume-Jensen Peter | President and CEO | May 18 | Grant / award · A | +180,095 | — | — | 2,259,046 |
| Devroe Eric | Chief Operating Officer | May 18 | Grant / award · A | +72,981 | — | — | 146,953 |
| Gamelin Erick | Chief Development Officer | May 18 | Grant / award · A | +38,584 | — | — | 52,992 |
| Levy Adam D. | Chief Financial Officer | May 18 | Grant / award · A | +46,167 | — | — | 67,150 |
| Miller Mary | Chief Legal Officer | May 18 | Grant / award · A | +49,830 | — | — | 82,767 |
| Mirza Mansoor Raza | Chief Medical Officer | May 18 | Grant / award · A | +38,817 | — | — | 38,817 |
| Peterson Katharine | Chief Accounting Officer | May 18 | Grant / award · A | +14,227 | — | — | 18,134 |
| Baum Charles M | Director | May 18 | Grant / award · A | +9,366 | — | — | 9,366 |
Loading...
